Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis

The European Respiratory Journal
Grazyna KwapiszewskaMalgorzata Wygrecka

Abstract

Despite the beneficial effects of pirfenidone in treating idiopathic pulmonary fibrosis (IPF), it remains unclear if lung fibroblasts (FB) are the main therapeutic target.To resolve this question, we employed a comparative transcriptomic approach and analysed lung homogenates (LH) and FB derived from IPF patients treated with or without pirfenidone.In FB, pirfenidone therapy predominantly affected growth and cell division pathways, indicating a major cellular metabolic shift. In LH samples, pirfenidone treatment was mostly associated with inflammation-related processes. In FB and LH, regulated genes were over-represented in the Gene Ontology node "extracellular matrix". We identified lower expression of cell migration-inducing and hyaluronan-binding protein (CEMIP) in both LH and FB from pirfenidone-treated IPF patients. Plasma levels of CEMIP were elevated in IPF patients compared to healthy controls and decreased after 7 months of pirfenidone treatment. CEMIP expression in FB was downregulated in a glioma-associated oncogene homologue-dependent manner and CEMIP silencing in IPF FB reduced collagen production and attenuated cell proliferation and migration.Cumulatively, our approach indicates that pirfenidone exerts beneficial...Continue Reading

References

Oct 6, 2000·American Journal of Respiratory Cell and Molecular Biology·R C SavaniN Khalil
Apr 6, 2002·Science·Priit TederPaul W Noble
Jan 9, 2004·The New England Journal of Medicine·Ganesh RaghuUNKNOWN Idiopathic Pulmonary Fibrosis Study Group
Jan 25, 2005·American Journal of Respiratory and Critical Care Medicine·Arata AzumaShoji Kudoh
May 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joëlle Marchal-SomméPaul Soler
Jul 4, 2006·The American Journal of Pathology·Katri KoliJorma Keski-Oja
Sep 29, 2007·American Journal of Respiratory and Critical Care Medicine·Talmadge E KingGanesh Raghu
Nov 3, 2007·American Journal of Respiratory and Critical Care Medicine·Marjukka MyllärniemiKatri Koli
May 10, 2008·The American Journal of Pathology·Ayumi YoshizakiShinichi Sato
Jun 6, 2009·American Journal of Respiratory and Critical Care Medicine·Varsha V GupteSaverio Bellusci
Dec 10, 2009·The European Respiratory Journal·H TaniguchiUNKNOWN Pirfenidone Clinical Study Group in Japan
Dec 17, 2009·American Journal of Respiratory and Critical Care Medicine·Craig E DanielsUNKNOWN Imatinib-IPF Study Investigators
Jan 9, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jeffrey J Swigris, Kevin K Brown
Jul 16, 2010·Expert Opinion on Therapeutic Targets·Steven D Rosen, Hassan Lemjabbar-Alaoui
Aug 14, 2010·American Journal of Respiratory Cell and Molecular Biology·Laszlo FarkasMartin Kolb
Oct 12, 2010·American Journal of Respiratory and Critical Care Medicine·Camille TailléBruno Crestani
May 17, 2011·Lancet·Paul W NobleUNKNOWN CAPACITY Study Group
Oct 25, 2011·Immunological Reviews·Robert C RickertAna V Miletic
May 8, 2013·Annals of Internal Medicine·Ganesh RaghuUNKNOWN ARTEMIS-IPF Investigators*
Jul 23, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jianmin XueSteven R Duncan
May 20, 2014·The New England Journal of Medicine·Talmadge E KingUNKNOWN ASCEND Study Group
Jul 16, 2015·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuUNKNOWN Latin American Thoracic Association
Dec 8, 2015·International Journal of Medical Sciences·David Alejandro Lopez-de la MoraJuan Armendariz-Borunda
Dec 10, 2015·The European Respiratory Journal·Paul W NobleTalmadge E King
Jun 15, 2016·American Journal of Respiratory and Critical Care Medicine·Harold R CollardFernando J Martinez
Dec 3, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Swathi BalajiSundeep G Keswani
Dec 16, 2016·The International Journal of Biochemistry & Cell Biology·Gunilla Westergren-ThorssonOskar Hallgren
Dec 17, 2016·Cellular and Molecular Gastroenterology and Hepatology·Artin SorooshCarol A de la Motte
Feb 6, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Miroslava DidiasovaMalgorzata Wygrecka
Oct 21, 2017·Nature Reviews. Disease Primers·Fernando J MartinezAthol U Wells

❮ Previous
Next ❯

Citations

Nov 24, 2018·The European Respiratory Journal·Argyris Tzouvelekis, Paul J Wolters
Mar 20, 2019·The European Respiratory Journal·Paul J Wolters, Vincent Cottin
Mar 3, 2020·Frontiers in Physiology·Shubha Gururaja RaoHarpreet Singh
Jan 4, 2019·International Journal of Environmental Research and Public Health·Shan LiuWenjun Ding
Apr 4, 2019·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Tobias VeitNikolaus Kneidinger
Oct 8, 2020·GeroScience·Jan Frohlich, Manlio Vinciguerra
Nov 7, 2019·Cellular Signalling·Matthias KrämerMalgorzata Wygrecka
Nov 20, 2020·European Respiratory Review : an Official Journal of the European Respiratory Society·Antoine FroidureArnaud Mailleux
May 1, 2021·International Journal of Molecular Sciences·Tomas KoltaiRosa A Cardone
Oct 30, 2021·Frontiers in Pharmacology·K M RoachP Bradding
Nov 23, 2021·Frontiers in Neuroscience·Gonzalo C Gutiérrez-TobalRoberto Hornero

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

© 2022 Meta ULC. All rights reserved